Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review
Abstract Background Treatment of solid malignancies has been revolutionized with the introduction of immune checkpoint inhibitors (ICIs) and their use is being expanded in therapy of different cancers. However, immune related adverse events (IRAEs) can occur during treatment. These side effects occu...
Main Authors: | Karam Khaddour, Veerpal Singh, Maryna Shayuk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5661-x |
Similar Items
-
Pembrolizumab-associated acral necrosis and esophageal necrosis
by: Austin Thomas, et al.
Published: (2022-12-01) -
Ipilimumab induced digital vasculitis
by: Amrita Padda, et al.
Published: (2018-02-01) -
Acral gangrene as a presentation of non-uremic calciphylaxis
by: Muhammad Hammadah, et al.
Published: (2013-10-01) -
Management of acral lentiginous melanoma: current updates and future directions
by: Michelle M. Dugan, et al.
Published: (2024-02-01) -
Acral Melanocytic Neoplasms: A Comprehensive Review of Acral Nevus and Acral Melanoma in Asian Perspective
by: Sanghyun Park, et al.
Published: (2022-08-01)